Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$10.39 - $16.07 $115,017 - $177,894
-11,070 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$8.89 - $24.94 $9,512 - $26,685
-1,070 Reduced 8.81%
11,070 $118,000
Q4 2019

Feb 14, 2020

BUY
$8.33 - $19.95 $2,865 - $6,862
344 Added 2.92%
12,140 $227,000
Q3 2019

Nov 12, 2019

BUY
$6.86 - $10.46 $80,920 - $123,386
11,796 New
11,796 $121,000
Q3 2018

Nov 14, 2018

SELL
$2.31 - $4.69 $4,070 - $8,263
-1,762 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$3.92 - $5.35 $14,868 - $20,292
-3,793 Reduced 68.28%
1,762 $9,000
Q4 2017

Feb 08, 2018

BUY
$3.9 - $4.66 $13,899 - $16,608
3,564 Added 179.01%
5,555 $22,000
Q3 2017

Nov 14, 2017

BUY
$4.14 - $5.12 $8,242 - $10,193
1,991
1,991 $9,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $102M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.